Links Explored Between Antidiabetic Meds, Multiple Sclerosis Risk

WEDNESDAY, Nov. 9, 2022 -- For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years and an increased...